A Gratitude Script for the COVID Vaccinated But Infected

A Gratitude Script for the COVID Vaccinated But Infected

“I would like to let you know that I have tested positive for #COVID19. I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms. I am isolating and have started a course of Paxlovid.” These were the words of Pfizer CEO Albert Bourla […]

Paxlovid Users May Face Rebound SARS-CoV-2

Paxlovid Users May Face Rebound SARS-CoV-2

The U.S. Centers for Disease Control and Prevention (CDC) has admitted that COVID-19 patients may experience a rebound SARS-CoV-2 infection after taking Pfizer’s antiviral drug, Paxlovid. Evidence has shown that patients, including those who have gotten COVID shots and been boosted, may suffer a reoccurrence of COVID two to eight days after completing a five-day […]

Moderna CEO Was Paid $18.2 Million in 2021

Moderna CEO Was Paid $18.2 Million in 2021

As COVID-19 vaccine sales continue to soar, Moderna Chief Executive Stephane Bancel’s total personal financial compensation increased by 41 percent in 2021, reaching $18.2 million. The company’s total revenue rose 2,200 percent in 2021, jumping from $803 million to $18.5 billion.1 2 Moderna partnered with the National Institute of Allergy and Infectious Diseases (NIAID), headed […]

Pfizer CEO Received $24.3 Million in Total Compensation for 2021

Pfizer CEO Received $24.3 Million in Total Compensation for 2021

Pfizer CEO Albert Bourla, who recently announced that a fourth COVID-19 vaccine dose will be necessary for everyone who has already gotten three doses, was awarded $24.3 million in personal financial compensation in 2021. In addition to his $1.69 million salary, which increased by 15 percent, Bourla took home a cash incentive of $8 million, […]

The Purge: Call Me Ishmael

The Purge: Call Me Ishmael

For the last 27 years, I have been a professor at Boston College, teaching a mix of literature and writing courses to thousands of students. Then along came the booster mandates. When the initial vaccines came out, my wife and I received ours. We had strong reservations about the mRNA vaccines and had decided we […]

Harvard Study’s Goal: Identifying Messages That ‘Break Through’ to Vaccine Skeptics

Harvard Study’s Goal: Identifying Messages That ‘Break Through’ to Vaccine Skeptics

“If only there were a message that could break through skepticism and persuade unvaccinated people to get their shots. What a world that would be. But over the past year, this really did happen,” reads a February 2022 Vox article1 that continues on to describe a Harvard Business School publication2 which offers new evidence on […]

Sales of Pfizer COVID-19 Biologic for 2021-2022 May Near $70 Billion

Sales of Pfizer COVID-19 Biologic for 2021-2022 May Near $70 Billion

Based on better than expected sales of its experimental messenger RNA (mRNA) BNT162b2 COVID-19 biologic, New York-based pharmaceutical company Pfizer, Inc. last summer revised projected sales of its experimental drug, also known as “Comirnaty,” from $26 billion to $33.5 billion in 2021. Characterizing second-quarter sales of BNT162b2 as “remarkable,” Pfizer’s chief executive officer (CEO) Albert […]

Omicron Found Mostly in Vaccinated Americans So Far

Omicron Found Mostly in Vaccinated Americans So Far

On Dec. 1, 2021, the first case of the new SARS-CoV-2 variant known as Omicron (initially designated “B.1.1.529”) in the United States was confirmed by the U.S. Centers for Disease Control and Prevention (CDC) in California. The case involves a fully vaccinated individual in San Francisco who had returned from a trip to South Africa […]

Pfizer Says Fourth COVID Shot May Be Needed, Fauci Talks About Annual Shots

Pfizer Says Fourth COVID Shot May Be Needed, Fauci Talks About Annual Shots

In an interview with CNBC on Dec. 8, 2021, Pfizer CEO Albert Bourla said that he expects sooner rather than later all Americans will have to get a fourth dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 to try to protect against the Omicron variant of the SARS-CoV-2 virus causing mostly mild COVID disease. […]